The prevalence of diabetes has reached alarming levels worldwide, prompting the need for innovative solutions in diabetes management. As individuals living with diabetes seek more effective and convenient ways to manage their condition, advancements in medical technology are playing a pivotal role. One such advancement is the development of GLP-1 (glucagon-like peptide-1) patch technology. This revolutionary approach aims to simplify medication delivery, enhance patient adherence, and ultimately improve health outcomes for those affected by diabetes. GLP-1 is a naturally occurring hormone that regulates insulin secretion, blood sugar levels, and appetite. Traditional methods of administering GLP-1 therapies, such as injections, often deter patients from adhering to their treatment plans due to…